Objectives:curve The aim of this work was to establish protein profiles in serum and nasal epithelial cells of Cystic Fibrosis individuals (AUC) in comparison with controls, asthma and chronic obstructive pulmonary disease patients for specific biomarker signatures identification. Design and Methods: Protein receiver extracts were analysed by Surface Enhanced Laser Desorption/Ionization Time-Of-Flight Mass-Spectrometry (SELDI-TOF-MS). Results: The mass spectra revealed a set of peaks better with differential expression in serum and nasal cells among the different groups studied, resulting into peak signatures representative/specific of each of pathology. Logistic regressions were applied to those peaks, sensitivity, specificity, Youden's indexes and area under the curve (AUC) of the with respective receiver operating characteristic (ROC) curves were compared. Discussion: Multivariate analysis demonstrated that combination of peaks have a better predictive may value than the individual ones. These protein signatures may serve as diagnostic/prognostic markers for the studied diseases with common clinical differential features, or as follow-up assessment markers of therapeutic interventions.

BACKGROUND:treatment Human memory and general cognitive abilities are complex functions of high heritability and wide variability in the population. The brain-derived in neurotrophic factor (BDNF) plays an important role in mammalian memory formation. METHODOLOGY / PRINCIPAL FINDING: Based on the identification of they genes markedly up-regulated during BDNF-induced synaptic consolidation in the hippocampus, we selected genetic variants that were tested in three independent located samples, from Norway and Scotland, of adult individuals examined for cognitive abilities. In all samples, we show that markers in of the doublecortin- and calmodulin kinase like 1 (DCLK1) gene, are significantly associated with general cognition (IQ scores) and verbal memory These function, resisting multiple testing. DCLK1 is a complex gene with multiple transcripts which vary in expression and function. We show affect that the short variants are all up-regulated after BDNF treatment in the rat hippocampus, and that they are expressed in and the adult human brain (mostly in cortices and hippocampus). We demonstrate that several of the associated variants are located in identification potential alternative promoter- and cis-regulatory elements of the gene and that they affect BDNF-mediated expression of short DCLK1 transcripts in with a reporter system. CONCLUSION: These data present DCLK1 as a functionally pertinent gene involved in human memory and cognitive functions.pertinent

BACKGROUND:controls. Induced sputum cytology and protein biomarkers can be employed to assess airways inflammation. Increases in sputum iron have been described Copper in inflammatory lung disease. We hypothesised that other sputum metals may be affected by airway inflammation and investigated their potential controls value as biomarkers. METHODS: Sputum was obtained from 20 healthy control subjects and patients with inflammatory pulmonary diseases: 23 with These cystic fibrosis (CF), 16 with bronchiectasis, 17 with asthma and 23 with COPD, and iron, zinc, manganese and copper were with measured. 14 CF patients were also studied through an exacerbation cycle. RESULTS: Sputum zinc and iron were elevated in CF in and non- CF bronchiectasis vs. controls (p < .001, Zinc; p< .01 Iron). Manganese was elevated in asthma (p< .01) and bronchiectasis airway (p< .05) versus controls. Copper was elevated in CF vs. controls (p< .05). Zinc decreased (p< .01) following treatment of CF exacerbation. In copper CF subjects zinc levels correlated with other biomarkers. CONCLUSIONS: These results suggest a relationship of high concentrations of total zinc inflammation and iron with airway inflammation in CF and non-CF bronchiectasis; longitudinal changes being observed in CF. Further work is required through to elucidate potential inflammatory mechanisms related to these observations.

A liquid clinical programme to assess whether lipid GL67A-mediated gene-transfer can ameliorate cystic fibrosis (CF) lung disease is currently being undertaken by height the UKCF Gene Therapy Consortium. We have evaluated GL67A gene transfer to the murine nasal epithelium of wildtype and CF even knockout mice to assess this tissue as a test site for gene transfer agents. The plasmids used were regulated by than either (a) the commonly used short-acting CMV promoter/enhancer or (b) the ubiquitin-C (UbC) promoter. In a study of approximately 400 to CF mice, vector-specific CFTR mRNA was detected in nasal epithelial cells of 82% of mice treated with a CMV-plasmid (pCF1-CFTR)non-viral and 62%-of mice treated with a UbC-plasmid. We then assessed whether CFTR gene-transfer corrected a panel of CFTR-specific endpoint assays phenotype in the murine nose including ion transport, periciliary liquid height and ex vivo bacterial adherence. Importantly, even with the comparatively vector-specific large number of animals assessed, the CFTR function studies were only powered to detect changes of more than 50% towards wildtype wild-type values. Within this limitation no significant correction of the CF phenotype was detected. At the currents levels of gene-transfer of efficiency achievable with non-viral vectors, the murine nose is of limited value as a stepping stone to human trials.

BACKGROUND:a Despite sharing 92% sequence identity, paralogous human translation elongation factor 1 alpha-1 (eEF1A1) and elongation factor 1 alpha-2 (eEF1A2) have cases different but overlapping functional profiles. This may reflect the differential requirements of the cell-types in which they are expressed and to is consistent with complex roles for these proteins that extend beyond delivery of tRNA to the ribosome. METHODOLOGY/PRINCIPAL FINDINGS: To the investigate the structural basis of these functional differences, we created and validated comparative three-dimensional (3-D) models of eEF1A1 and eEF1A2 reconcile on the basis of the crystal structure of homologous eEF1A from yeast. The spatial location of amino acid residues that phosphorylation vary between the two proteins was thereby pinpointed, and their surface electrostatic and lipophilic properties were compared. None of the enable variations amongst buried amino acid residues are judged likely to have a major structural effect on the protein fold, or to to affect domain-domain interactions. Nearly all the variant surface-exposed amino acid residues lie on one face of the protein, in To two proximal but distinct sub-clusters. The result of previously performed mutagenesis in yeast may be interpreted as confirming the importance interactions. of one of these clusters in actin-bundling and filament disorganization. Interestingly, some variant residues lie in close proximity to, and mutagenesis. in a few cases show differences in interactions with, residues previously inferred to be directly involved in binding GTP/GDP, eEF1Balpha residues and aminoacyl-tRNA. Additional sequence-based predictions, in conjunction with the 3-D models, reveal likely differences in phosphorylation sites that could reconcile variant some of the functional differences between the two proteins. CONCLUSIONS: The revelation and putative functional assignment of two distinct sub-clusters actin-bundling on the surface of the protein models should enable rational site-directed mutagenesis, including homologous reverse-substitution experiments, to map surface binding actin-bundling patches onto these proteins. The predicted variant-specific phosphorylation sites also provide a basis for experimental verification by mutagenesis. The models domain-domain provide a structural framework for interpretation of the resulting functional analysis.

BACKGROUND:immunocytochemistry To assess gene therapy treatment for cystic fibrosis (CF) in clinical trials it is essential to develop robust assays that method can accurately detect transgene expression in human airway epithelial cells. Our aim was to develop a reproducible immunocytochemical assay for and human CFTR protein which can measure both endogenous CFTR levels and augmented CFTR expression after gene delivery. METHODS: We characterised protein an antibody (G449) which satisfied the criteria for use in clinical trials. We optimised our immunocytochemistry method and identified G449 RNA dilutions at which endogenous CFTR levels were negligible in CF samples, thus enhancing detection of transgenic CFTR protein. After developing protein a transfection technique for brushed human nasal epithelial cells, we transfected non-CF and CF cells with a clinically relevant CpG-free We plasmid encoding human CFTR. RESULTS: The optimised immunocytochemistry method gave improved discrimination between CF and non-CF samples. Transfection of a at CFTR expression vector into primary nasal epithelial cells resulted in detectable RNA and protein expression. CFTR protein was present in immunocytochemical .05-10% of non-CF cells and .02- .8% of CF cells. CONCLUSION: We have developed a sensitive, clinically relevant immunocytochemical assay for samples, CFTR protein and have used it to detect transgene-expressed CFTR in transfected human primary airway epithelial cells.

Bipolar schizophrenia disorder, schizophrenia and recurrent major depression are complex psychiatric illnesses with a substantial, yet unknown genetic component. Linkage of bipolar but disorder and recurrent major depression with markers on chromosome 4p15-p16 has been identified in a large Scottish family and three P= .005, smaller families. Analysis of haplotypes in the four chromosome 4p-linked families, identified two regions, each shared by three of the showed four families, which are also supported by a case-control association study. The candidate gene phosphatidylinositol 4-kinase type-II beta (PI4K2B) lies of within one of these regions. PI4K2B is a strong functional candidate as it is a member of the phosphatidylinositol pathway,contributing which is targeted by lithium for therapeutic effect in bipolar disorder. Two approaches were undertaken to test the PI4K2B candidate between gene as a susceptibility factor for psychiatric illness. First, a case-control association study, using tagging SNPs from the PI4K2B genomic which region, in bipolar disorder (n=368), schizophrenia (n=386) and controls (n=458) showed association with a two-marker haplotype in schizophrenia but not the bipolar disorder (rs10939038 and rs17408391, global P= .005, permuted global P= .039). Second, expression studies at the allele-specific mRNA and protein level approaches using lymphoblastoid cell lines from members of the large Scottish family, which showed linkage to 4p15-p16 in bipolar disorder and a recurrent major depression, showed no difference in expression differences between affected and non-affected family members. There is no evidence to and suggest that PI4K2B is contributing to bipolar disorder in this family but a role for this gene in schizophrenia has undertaken not been excluded.

Genetic the biobanking studies are becoming increasingly common as researchers recognise the need for large samples to identify the genetic basis of the susceptibility to complex disease. In the present review, the authors give a brief overview of some of the issues that and should be considered when implementing such a large-scale project, from study design to sample management, data coding and storage to are the statistical analysis and engagement with the public. Specific solutions to these issues are presented, as implemented in the Generation these Scotland projects, but the general principles outlined are relevant to any biobanking study.

Zebrafish specific rapidly alter their pigmentation in response to environmental changes. For black melanocytes, this change is due to aggregation or dispersion phosphodiesterase of melanin in the cell. Dispersion and aggregation are controlled by intracellular cyclic adenosine monophosphate (cAMP) levels, which increase upon dispersal. stimulation by alpha melanocyte-stimulating hormone (alpha-MSH) or reduce with melanin-concentrating hormone (MCH). In mammals and birds, the melanocortin-1-receptor (MC1R) responds the to MSH, and stimulates the synthesis of black eumelanin. While MSH-cAMP signaling stimulates melanogenesis in mammals, and melanosome dispersal in of cold-blood vertebrates, the pathway components are highly conserved. However, it has only been assumed that mc1r mediates melanosome dispersal in modification fish. Here, using morpholino oligonucleotides designed to knockdown mc1r expression, we find that mc1r morphants are unable to disperse melanosomes for when grown in dark conditions. We also use chemical modifiers of the cAMP pathway, and find an unexpected response to has the specific phosphodiesterase 4 (PDE4) inhibitor, rolipram, in melanosome dispersal. When treated with the drug, melanosomes fail to fully disperse by in dark conditions, despite presumed increased levels of cAMP, and in contrast to the effects of the nonselective PDE inhibitor,fish. 3-isobutyl-1-methylxanthine. In conclusion, we demonstrate a direct role for mc1r in zebrafish melanosome dispersal in response to background, and use possible chemical modification of this pathway to uncover a possible new layer of regulation in melanosome dispersal in zebrafish.